Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

[Erratum to: Diagnosis and treatment of interstitial cystitis (IC/PBS). S2k guideline of the German Society of Urology].

Bschleipfer T, Doggweiler R, Schultz-Lampel D, de Jong J, Gonsior A, Hensen J, Heßdörfer E, Kaftan BT, Kuhn A, Kunzendorf U, Lampel A, Landmesser A, Loch A, Moormann O, Müller B, Neuhaus J, Reich A, Roth R, Schumacher S, Stratmeyer R, Vahlensieck W, Wördehoff A, Münder-Hensen B.

Urologe A. 2019 Dec;58(12):1498. doi: 10.1007/s00120-019-01076-w. German. No abstract available.

PMID:
31776628
2.

[Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Bschleipfer T, Doggweiler R, Schultz-Lampel D, de Jong J, Gonsior A, Hensen J, Heßdörfer E, Kaftan BT, Kuhn A, Kunzendorf U, Lampel A, Landmesser A, Loch A, Moormann O, Müller B, Neuhaus J, Reich A, Roth R, Schumacher S, Stratmeyer R, Vahlensieck W, Wördehoff A, Münder-Hensen B.

Urologe A. 2019 Nov;58(11):1313-1323. doi: 10.1007/s00120-019-01054-2. Review. German. Erratum in: Urologe A. 2019 Dec;58(12):1498.

PMID:
31659368
3.

Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.

Schulte K, Schierke H, Tamayo M, Hager L, Engehausen R, Raspe M, Hübner RH, Schlieper G, Borzikowsky C, Urbschat A, Auerswald S, Kunzendorf U, Feldkamp T.

Dtsch Arztebl Int. 2019 Jun 10;116(23-24):413-419. doi: 10.3238/arztebl.2019.0413.

4.

Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis.

Schulte K, Püchel J, Schüssel K, Borzikowsky C, Kunzendorf U, Feldkamp T.

Transplant Direct. 2019 Jun 27;5(7):e464. doi: 10.1097/TXD.0000000000000910. eCollection 2019 Jul.

5.

[Reasons for the low organ donation rate in Germany].

Schulte K, Kunzendorf U, Feldkamp T.

Urologe A. 2019 Aug;58(8):888-892. doi: 10.1007/s00120-019-0962-x. Review. German.

PMID:
31161234
6.

Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation.

Moerke C, Bleibaum F, Kunzendorf U, Krautwald S.

Front Cell Dev Biol. 2019 Feb 20;7:19. doi: 10.3389/fcell.2019.00019. eCollection 2019.

7.

Analysis of the Eurotransplant Kidney Allocation Algorithm: How Should We Balance Utility and Equity?

Schulte K, Klasen V, Vollmer C, Borzikowsky C, Kunzendorf U, Feldkamp T.

Transplant Proc. 2018 Dec;50(10):3010-3016. doi: 10.1016/j.transproceed.2018.08.040. Epub 2018 Sep 7.

PMID:
30577160
8.

The anticonvulsive Phenhydan® suppresses extrinsic cell death.

Moerke C, Jaco I, Dewitz C, Müller T, Jacobsen AV, Gautheron J, Fritsch J, Schmitz J, Bräsen JH, Günther C, Murphy JM, Kunzendorf U, Meier P, Krautwald S.

Cell Death Differ. 2019 Sep;26(9):1631-1645. doi: 10.1038/s41418-018-0232-2. Epub 2018 Nov 15.

9.

Decline in Organ Donation in Germany.

Schulte K, Borzikowsky C, Rahmel A, Kolibay F, Polze N, Fränkel P, Mikle S, Alders B, Kunzendorf U, Feldkamp T.

Dtsch Arztebl Int. 2018 Jul 9;115(27-28):463-468. doi: 10.3238/arztebl.2018.0463.

10.

Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.

Feldkamp T, Luedemann M, Spehlmann ME, Freitag-Wolf S, Gaensbacher J, Schulte K, Bajrovic A, Hinzmann D, Hippe HJ, Kunzendorf U, Frey N, Luedde M.

Clin Res Cardiol. 2018 Feb;107(2):148-157. doi: 10.1007/s00392-017-1166-2. Epub 2017 Sep 22.

PMID:
28939956
11.

Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.

Müller T, Dewitz C, Schmitz J, Schröder AS, Bräsen JH, Stockwell BR, Murphy JM, Kunzendorf U, Krautwald S.

Cell Mol Life Sci. 2017 Oct;74(19):3631-3645. doi: 10.1007/s00018-017-2547-4. Epub 2017 May 27.

12.

Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism.

Schulte K, Vollmer C, Klasen V, Bräsen JH, Püchel J, Borzikowsky C, Kunzendorf U, Feldkamp T.

J Nephrol. 2017 Aug;30(4):607-615. doi: 10.1007/s40620-017-0411-0. Epub 2017 May 24.

PMID:
28540602
13.

Necroptosis Execution Is Mediated by Plasma Membrane Nanopores Independent of Calcium.

Ros U, Peña-Blanco A, Hänggi K, Kunzendorf U, Krautwald S, Wong WW, García-Sáez AJ.

Cell Rep. 2017 Apr 4;19(1):175-187. doi: 10.1016/j.celrep.2017.03.024.

14.

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.

Beneke J, Sartison A, Kielstein JT, Haller H, Nitschke M, Kunzendorf U, Loos S, Kemper MJ, Stahl RA, Menne J; German 2011 STEC-HUS outbreak study group.

Transfus Med Rev. 2017 Jan;31(1):51-55. doi: 10.1016/j.tmrv.2016.06.004. Epub 2016 Jun 21.

PMID:
27468945
15.

Inhibition of regulated cell death by cell-penetrating peptides.

Krautwald S, Dewitz C, Fändrich F, Kunzendorf U.

Cell Mol Life Sci. 2016 Jun;73(11-12):2269-84. doi: 10.1007/s00018-016-2200-7. Epub 2016 Apr 5. Review.

16.

Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results.

Krämer BK, Montagnino G, Krüger B, Margreiter R, Olbricht CJ, Marcen R, Sester U, Kunzendorf U, Dietl KH, Rigotti P, Ronco C, Hörsch S, Banas B, Mühlbacher F, Arias M; European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.

Transpl Int. 2016 Mar;29(3):307-14. doi: 10.1111/tri.12716. Epub 2015 Dec 11.

17.

Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease.

Zschiedrich S, Budde K, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hoerl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Lindner TH, Faerber L, Wimmer P, Stork R, Eckardt KU, Walz G.

Nephrol Dial Transplant. 2016 Feb;31(2):284-9. doi: 10.1093/ndt/gfv077. Epub 2015 Apr 1.

PMID:
25832108
18.

Synchronized renal tubular cell death involves ferroptosis.

Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz PS, Weinlich R, Vanden Berghe T, Vandenabeele P, Pasparakis M, Bleich M, Weinberg JM, Reichel CA, Bräsen JH, Kunzendorf U, Anders HJ, Stockwell BR, Green DR, Krautwald S.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16836-41. doi: 10.1073/pnas.1415518111. Epub 2014 Nov 10.

19.

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus.

Bruckmueller H, Werk AN, Renders L, Feldkamp T, Tepel M, Borst C, Caliebe A, Kunzendorf U, Cascorbi I.

Ther Drug Monit. 2015 Jun;37(3):288-95. doi: 10.1097/FTD.0000000000000142.

PMID:
25271728
20.

Regulated cell death in AKI.

Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z.

J Am Soc Nephrol. 2014 Dec;25(12):2689-701. doi: 10.1681/ASN.2014030262. Epub 2014 Jun 12. Review.

21.

Phosphorylated MLKL causes plasma membrane rupture.

Linkermann A, Kunzendorf U, Krautwald S.

Mol Cell Oncol. 2014 Aug 13;1(1):e29915. doi: 10.4161/mco.29915. eCollection 2014. No abstract available.

22.

Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysis.

Koch T, Derer S, Staudinger M, Rossen K, Glorius P, Peipp M, Kellner C, Kunzendorf U, Valerius T, Dechant M.

Am J Nephrol. 2013;38(5):379-87. doi: 10.1159/000355972. Epub 2013 Oct 23.

PMID:
24157422
23.

Necroptosis in immunity and ischemia-reperfusion injury.

Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM.

Am J Transplant. 2013 Nov;13(11):2797-804. doi: 10.1111/ajt.12448. Epub 2013 Sep 18. Review.

24.

The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice.

Linkermann A, Heller JO, Prókai A, Weinberg JM, De Zen F, Himmerkus N, Szabó AJ, Bräsen JH, Kunzendorf U, Krautwald S.

J Am Soc Nephrol. 2013 Oct;24(10):1545-57. doi: 10.1681/ASN.2012121169. Epub 2013 Jul 5. Erratum in: J Am Soc Nephrol. 2014 Dec;25(12):2942.

25.

Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.

Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO, De Zen F, Weinlich R, Ortiz A, Walczak H, Weinberg JM, Green DR, Kunzendorf U, Krautwald S.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12024-9. doi: 10.1073/pnas.1305538110. Epub 2013 Jul 1.

26.

The authors reply.

Linkermann A, Kunzendorf U, Krautwald S.

Kidney Int. 2013 Mar;83(3):531. doi: 10.1038/ki.2012.471. No abstract available.

27.

Programmed necrosis in acute kidney injury.

Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S.

Nephrol Dial Transplant. 2012 Sep;27(9):3412-9. doi: 10.1093/ndt/gfs373. Review.

PMID:
22942173
28.

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium.

BMJ. 2012 Jul 19;345:e4565. doi: 10.1136/bmj.e4565.

29.

Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock.

Linkermann A, Bräsen JH, De Zen F, Weinlich R, Schwendener RA, Green DR, Kunzendorf U, Krautwald S.

Mol Med. 2012 May 9;18:577-86. doi: 10.2119/molmed.2011.00423.

30.

Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.

Linkermann A, Bräsen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S.

Kidney Int. 2012 Apr;81(8):751-61. doi: 10.1038/ki.2011.450. Epub 2012 Jan 11.

31.

Recent outbreak of hemolytic uremic syndrome in Germany.

Kunzendorf U, Karch H, Werber D, Haller H.

Kidney Int. 2011 Nov;80(9):900-2. doi: 10.1038/ki.2011.323. No abstract available.

32.

Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure.

Linkermann A, Himmerkus N, Rölver L, Keyser KA, Steen P, Bräsen JH, Bleich M, Kunzendorf U, Krautwald S.

Kidney Int. 2011 Jan;79(2):169-78. doi: 10.1038/ki.2010.317. Epub 2010 Sep 1.

33.

Everolimus in patients with autosomal dominant polycystic kidney disease.

Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU.

N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26. Erratum in: N Engl J Med. 2010 Nov 11;363(20):1977. N Engl J Med. 2010 Sep 16;363(12):1190.

34.

Novel aspects of pharmacological therapies for acute renal failure.

Kunzendorf U, Haase M, Rölver L, Haase-Fielitz A.

Drugs. 2010 Jun 18;70(9):1099-114. doi: 10.2165/11535890-000000000-00000. Review.

PMID:
20518578
35.

Effective blockage of both the extrinsic and intrinsic pathways of apoptosis in mice by TAT-crmA.

Krautwald S, Ziegler E, Rölver L, Linkermann A, Keyser KA, Steen P, Wollert KC, Korf-Klingebiel M, Kunzendorf U.

J Biol Chem. 2010 Jun 25;285(26):19997-20005. doi: 10.1074/jbc.M110.122127. Epub 2010 Apr 28.

36.

Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.

Braun F, Schöcklmann H, Ziegler E, Kunzendorf U, Armstrong VW, Renders L.

Clin Pharmacol Ther. 2009 Oct;86(4):411-5. doi: 10.1038/clpt.2009.129. Epub 2009 Jul 15.

PMID:
19606088
37.

Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible.

Hutchinson JA, Gövert F, Riquelme P, Bräsen JH, Brem-Exner BG, Matthäi M, Schulze M, Renders L, Kunzendorf U, Geissler EK, Fändrich F.

Clin Transplant. 2009 Jan-Feb;23(1):140-5. doi: 10.1111/j.1399-0012.2008.00953.x.

PMID:
19200227
38.

Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation.

Hutchinson JA, Riquelme P, Brem-Exner BG, Schulze M, Matthäi M, Renders L, Kunzendorf U, Geissler EK, Fändrich F.

Transpl Int. 2008 Aug;21(8):728-41. doi: 10.1111/j.1432-2277.2008.00680.x. Epub 2008 Jul 10.

39.

A cell-based approach to the minimization of immunosuppression in renal transplantation.

Hutchinson JA, Brem-Exner BG, Riquelme P, Roelen D, Schulze M, Ivens K, Grabensee B, Witzke O, Philipp T, Renders L, Humpe A, Sotnikova A, Matthäi M, Heumann A, Gövert F, Schulte T, Kabelitz D, Claas FH, Geissler EK, Kunzendorf U, Fändrich F.

Transpl Int. 2008 Aug;21(8):742-54. doi: 10.1111/j.1432-2277.2008.00692.x. Epub 2008 Jul 10.

40.

Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells.

Hutchinson JA, Roelen D, Riquelme P, Brem-Exner BG, Witzke O, Philipp T, Matthäi M, Gövert F, Claas FH, Westphal E, Kunzendorf U, Geissler EK, Fändrich F.

Transpl Int. 2008 Aug;21(8):808-13. doi: 10.1111/j.1432-2277.2008.00712.x. Epub 2008 Jul 10.

41.

Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.

Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G; European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2386-92. doi: 10.1093/ndt/gfn004. Epub 2008 Feb 7.

PMID:
18258740
42.

Bone disease after renal transplantation.

Kunzendorf U, Krämer BK, Arns W, Braun J, Grossmann J, Pietruck F, Schmidt-Gayk H, Schwarz A, Ziegler E, Sperschneider H, Wüthrich RP, Nonnast-Daniel B, Schindler R, Renders L.

Nephrol Dial Transplant. 2008 Feb;23(2):450-8. Epub 2007 Dec 1. Review. No abstract available.

43.

CCR7 signaling inhibits T cell proliferation.

Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, Förster R, Kunzendorf U, Krautwald S.

J Immunol. 2007 Nov 15;179(10):6485-93.

44.

[Chronic renal failure and transplantation].

Kunzendorf U, Renders L, Ziegler E.

Internist (Berl). 2007 Aug;48(8):804-12. German.

PMID:
17628765
45.

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients.

Renders L, Frisman M, Ufer M, Mosyagin I, Haenisch S, Ott U, Caliebe A, Dechant M, Braun F, Kunzendorf U, Cascorbi I.

Clin Pharmacol Ther. 2007 Feb;81(2):228-34. Epub 2006 Dec 27.

PMID:
17192769
46.

Images in clinical medicine. Radiographic appearance of lanthanum.

Cerny S, Kunzendorf U.

N Engl J Med. 2006 Sep 14;355(11):1160. No abstract available.

47.

CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.

Ziegler E, Gueler F, Rong S, Mengel M, Witzke O, Kribben A, Haller H, Kunzendorf U, Krautwald S.

J Am Soc Nephrol. 2006 Sep;17(9):2521-32. Epub 2006 Aug 9.

48.

FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.

Mulgaonkar S, Tedesco H, Oppenheimer F, Walker R, Kunzendorf U, Russ G, Knoflach A, Patel Y, Ferguson R; FTYA121 study group.

Am J Transplant. 2006 Aug;6(8):1848-57. Epub 2006 Jun 12. Erratum in: Am J Transplant. 2006 Dec;6(12):3044.

49.

Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.

Margreiter R, Pohanka E, Sparacino V, Sperschneider H, Kunzendorf U, Huber W, Lameire N, Andreucci VE, Donati D, Heemann U; European Switch to Tacrolimus Study Group.

Transpl Int. 2005 Jul;18(7):816-23.

50.

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.

Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M; European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.

Nephrol Dial Transplant. 2005 May;20(5):968-73. Epub 2005 Mar 1.

PMID:
15741208

Supplemental Content

Loading ...
Support Center